Epoch Investment Partners Inc. has $203M position in HCA Healthcare, Inc. (NYSE:HCA)

Epoch Investment Partners Inc. increased its stake in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 16.4% during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 631,854 shares of the company’s stock after purchasing an additional 88,948 shares during the period. HCA Healthcare accounts for about 0.9% of Epoch Investment Partners Inc.’s holdings, making the stock its 21st largest holding. Holdings of Epoch Investment Partners Inc. holdings in HCA Healthcare were worth $203,002,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in HCA. Bangor Savings Bank boosted its stake in HCA Healthcare by 112.5% ​​during the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after buying an additional 45 shares in the period time. MFA Wealth Advisors LLC purchased a new stake in shares of HCA Healthcare in the second quarter valued at about $27,000. Unique Wealth Strategies LLC bought a new stake in HCA Healthcare during the second quarter valued at about $28,000. GPS Wealth Strategies Group LLC boosted its stake in HCA Healthcare by 284.0% in the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after purchasing an additional 71 shares in the last quarter. Finally, LifeSteps Financial Inc. purchased a new stake in shares of HCA Healthcare in the first quarter worth $33,000. Institutional investors own 62.73% of the company’s shares.

The Wall Street analyst weighs in

HCA has been the subject of a number of research reports. UBS Group upped their target price on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a report on Wednesday, August 14th. Truist Financial boosted their price target on HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, August 19th. Barclays raised their price objective on shares of HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a report on Wednesday, July 24th. Wells Fargo & Company boosted their target price on shares of HCA Healthcare from $315.00 to $365.00 and gave the company an “equal weight” rating in a research report on Tuesday, July 30th. Finally, Oppenheimer boosted their price objective on shares of HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 24th. Five investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have assigned a strong buy rating to the company. HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $359.89, according to MarketBeat.

Get the latest analysis on HCA Healthcare

HCA Healthcare stock rose 0.3%

Shares of HCA Healthcare stock opened at $404.66 on Friday. HCA Healthcare, Inc. has a twelve month low of $215.96 and a twelve month high of $405.70. The stock has a market cap of $105.99 billion, a P/E ratio of 20.17, a P/E/G ratio of 1.46 and a beta of 1.67. The company’s 50-day moving average price is $370.57, and its two-hundred-day moving average price is $340.65. The company has a quick ratio of 0.94, a current ratio of 1.06, and a debt-to-equity ratio of 27.11.

HCA Healthcare (NYSE:HCA – Get Free Report ) last issued its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. The firm had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The company’s revenue for the quarter was up 10.3% year over year. During the same period in the previous year, the firm posted EPS of $4.29. As a group, analysts expect that HCA Healthcare, Inc. to post 22.46 EPS for the current year.

HCA Healthcare announces dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be given a $0.66 dividend. The ex-dividend date is Monday, September 16. This represents a dividend of $2.64 on an annualized basis and a dividend yield of 0.65%. HCA Healthcare’s payout ratio is 13.16%.

Insider buying and selling

In other news, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction on Monday, July 29th. The shares were sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the sale, the senior vice president now directly owns 40,449 shares of the company’s stock, valued at approximately $14,569,729.80. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC’s website. In related news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares in the company, valued at approximately $11,438,494.76. The sale was disclosed in a filing with the SEC, which is available at this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the completion of the transaction, the senior vice president now owns 40,449 shares in the company, valued at approximately $14,569,729.80. The disclosure for this sale can be found here. Insiders have sold 17,202 shares of company stock worth $6,407,273 over the last 90 days. 1.60% of shares are held by corporate insiders.

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that provide medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic and emergency services; and outpatient services such as ambulatory surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured stories

Want to see what other hedge funds own HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trading for HCA Healthcare, Inc. (NYSE:HCA – Free Report).

Get news and reviews for HCA Healthcare Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for HCA Healthcare and related companies with MarketBeat.com’s FREE daily email newsletter.